[go: up one dir, main page]

IL156839A0 - Use of chromanes - Google Patents

Use of chromanes

Info

Publication number
IL156839A0
IL156839A0 IL15683902A IL15683902A IL156839A0 IL 156839 A0 IL156839 A0 IL 156839A0 IL 15683902 A IL15683902 A IL 15683902A IL 15683902 A IL15683902 A IL 15683902A IL 156839 A0 IL156839 A0 IL 156839A0
Authority
IL
Israel
Prior art keywords
chromanes
Prior art date
Application number
IL15683902A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL156839A0 publication Critical patent/IL156839A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15683902A 2001-01-16 2002-01-03 Use of chromanes IL156839A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10101917A DE10101917A1 (de) 2001-01-16 2001-01-16 Verwendung von Chromanen
PCT/EP2002/000007 WO2002055078A2 (de) 2001-01-16 2002-01-03 Verwendung von chromanen zur behandlung von parkinson

Publications (1)

Publication Number Publication Date
IL156839A0 true IL156839A0 (en) 2004-02-08

Family

ID=7670832

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15683902A IL156839A0 (en) 2001-01-16 2002-01-03 Use of chromanes

Country Status (17)

Country Link
US (1) US20020177616A1 (es)
EP (1) EP1353670A2 (es)
JP (1) JP2004520342A (es)
KR (1) KR20040025885A (es)
CN (1) CN1529596A (es)
AR (1) AR032070A1 (es)
BR (1) BR0206475A (es)
CA (1) CA2436811A1 (es)
DE (1) DE10101917A1 (es)
GT (1) GT200200002A (es)
IL (1) IL156839A0 (es)
MX (1) MXPA03006333A (es)
PE (1) PE20020841A1 (es)
PL (1) PL362869A1 (es)
SV (1) SV2003000843A (es)
UY (1) UY27123A1 (es)
WO (1) WO2002055078A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2272771T3 (es) * 2001-09-12 2007-05-01 Merck Patent Gmbh Uso de aminometil cromanos sustituidos en el tratamiento de transtornos extrapirimidales del movimiento.
EP1856126A2 (en) * 2005-02-17 2007-11-21 Wyeth a Corporation of the State of Delaware Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
US9066903B2 (en) * 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
DE19754573A1 (de) * 1997-12-09 1999-06-10 Bayer Ag Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma

Also Published As

Publication number Publication date
KR20040025885A (ko) 2004-03-26
GT200200002A (es) 2002-09-02
EP1353670A2 (de) 2003-10-22
US20020177616A1 (en) 2002-11-28
WO2002055078A3 (de) 2003-03-13
WO2002055078A2 (de) 2002-07-18
JP2004520342A (ja) 2004-07-08
UY27123A1 (es) 2002-08-30
CA2436811A1 (en) 2002-07-18
PE20020841A1 (es) 2002-10-02
DE10101917A1 (de) 2002-07-18
PL362869A1 (en) 2004-11-02
AR032070A1 (es) 2003-10-22
BR0206475A (pt) 2003-12-30
MXPA03006333A (es) 2004-04-20
SV2003000843A (es) 2003-01-13
CN1529596A (zh) 2004-09-15

Similar Documents

Publication Publication Date Title
PT1438306E (pt) Derivados de uk-20
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
SI1360169T1 (sl) Sukcinatna sol o-desmetil-venlafaksina
EP1387687A4 (en) NEW USE
GB0100762D0 (en) Novel use
GB0115181D0 (en) Novel use
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB0123120D0 (en) Method of attachment
IL188485A0 (en) New use of iloperidone
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
IL156839A0 (en) Use of chromanes
TW493722U (en) Improved structure of lampwick
HU0104370D0 (en) Honeyed schnaps of oerseg
GB0125482D0 (en) Uses of (s)-clenbuterol
TW573751U (en) Structure capable of preventing jaming
GB0126000D0 (en) Use of 4ñ Phorbol
TW494780U (en) Structure of swimmeret
GB2381908A8 (en) Integrated vertical-horizontal multi-portal
TW510530U (en) New structure of micro-radiator
TW510531U (en) New structure of micro-radiator
TW511737U (en) New structure of micro-radiator
PL347345A1 (en) Non-ionic derivatives of bisalkanoyl bisglucamines
GB0109520D0 (en) Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors
TW501859U (en) Improvement of fixing-stand structure
PL351273A1 (en) Novel derivatives of benzoimidazole